We have mainly grown organically, but have bolstered our growth through a number of strategic acquisitions which have broadened our service portfolio and have added scale to existing services.
2021
ICON acquires PRA Health Sciences, creating the most advanced healthcare intelligence and clinical research organisation in the world
2020
ICON acquires MedPass International, a leading European medical device CRO, regulatory and reimbursement consultancy
2019
ICON acquires Symphony Clinical Research, a leading provider of at-home patient services and site support services
ICON acquires MediNova, an integrated network of clinical research sites across EMEA
ICON acquires MolecularMD to enhance laboratory offering in molecular diagnostic testing and immunohistochemistry
2017
ICON acquires MAPI Group to become world’s 2nd largest provider of late phase services
2016
ICON acquires Clinical Research Management Inc. to extend presence in the government sponsored research market
ICON selected by Genomics England to support the world's largest genome sequencing project
ICON selected by ICHOM to develop world’s first global healthcare outcomes benchmarking programme
2015
ICON celebrates 25 years
ICON creates new global innovation hub in Ireland to advance clinical development
ICON acquires MediMedia Pharma Solutions to enhance market access and scientific communications capabilities
ICON acquires PMG Research Inc, an integrated network of clinical research sites in the US
ICON launches Medical Device and Diagnostics Research Group
2014
ICON acquires Aptiv Solutions, a market leader in adaptive trial design and execution
2013
ICON acquires staffing and FSP providers, ClinForce and Assent
ICON acquires Akos, an EU Provider of Pharmacovigilance and Drug Safety Services
2012
ICON acquires PriceSpective, a global value strategy consultancy
ICON acquires Chinese CRO, BeijingWits
2011
ICON acquires Oxford Outcomes, an international health outcomes consultancy
ICON acquires Firecrest Clinical, a technology provider specialising in site performance and study management
2010
ICON acquires Timaq Medical Imaging Inc.
2009
ICON acquires Veeda Laboratories, a UK Biomarker Lab
2008
ICON acquires US Phase I Provider Healthcare Discoveries
ICON acquires US Bioanalytical Lab, Prevalere Life Sciences
2007
ICON acquires European staffing group, DOCS International
2006
ICON acquires Outcomes Research and Health Economics specialist, Ovation Research Group
2005
ICON opens first Indian office in Chennai
2004
ICON acquires medical imaging specialist, Beacon Bioscience Inc.
2003
ICON acquires Medeval, a UK-based Phase I facility
